Extracorporeal membrane oxygenation, or ECMO, is one of the most serious life support measures offered at a hospital, with critically ill patients often receiving both heart and lung support for a number of days or weeks during organ and respiratory failure.
During the initial months of the COVID-19 pandemic, patients sickened most severely with the virus were moved to ECMO after ventilation failed, with a 50% survival rate.